This Week in Oncology: Gastric Cancer, Bladder Risk, and Robotic Surgery

From the New England Journal of Medicine, a trial reported on immune checkpoint inhibitor regimens versus chemotherapy for patients with advanced gastric cancer. The analysis indicated that dual-target inhibitor combinations may offer survival benefits, though the authors note these findings await head-to-head trial confirmation ^[1].

Meanwhile, researchers turned their attention to risk factors, finding a link between body weight and malignancy. A meta-analysis examined data from 30 international cohort studies involving 2,533,008 participants to assess bladder cancer risk. The results suggested that higher BMI and waist circumference are associated with an increased risk of incident bladder cancer in males, but not in females ^[2].

Elsewhere this week, the focus shifted to surgical techniques for esophageal and rectal cancers. In Journal of robotic surgery, a systematic review of 13,321 patients indicated that robot-assisted minimally invasive esophagectomy offers perioperative benefits like reduced blood loss and shorter hospital stays compared to conventional approaches. However, the evidence certainty was described as very low due to the predominance of non-randomized studies ^[3].

A separate study in Techniques in coloproctology involved a large meta-analysis of 27,648 patients undergoing total mesorectal excision for rectal cancer. This work indicated that robotic surgery yields more complete specimens and fewer positive distal margins, although the evidence certainty remained low due to selection bias ^[4].

We also saw research in JBJS reviews addressing orthopedic reconstruction after tumor resection. This systematic review and meta-analysis synthesized evidence on proximal tibia reconstruction methods for oncologic indications. The findings suggested that prosthetic reconstruction had the lowest overall complication rate, while biological methods were associated with higher failure rates in proximal tibia tumor reconstruction ^[5].

Collectively, these studies highlight the evolving landscape of treatment options, from immunotherapy combinations to refined surgical approaches, while underscoring the need for further high-quality evidence to solidify current practices.